The regulatory role of IL-37 and IL-38 in CAR-T associated cytokine release syndrome in multiple myeloma - Top-Institutions - MDSpire

The regulatory role of IL-37 and IL-38 in CAR-T associated cytokine release syndrome in multiple myeloma

  • By

  • Xiujuan Huang

  • Hailong Yan

  • Jiaojiao Bai

  • Shisan Bao

  • Yi Wang

  • Qiuying Gao

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Sydney
    University of Sydney

    Sydney, NSW

    Key Differentiators

    • Hematology

  • #2

    Royal Prince Alfred Hospital
    Royal Prince Alfred Hospital

    Sydney, NSW

    Key Differentiators

    • Hematology

  • #3

    University of Pennsylvania
    University of Pennsylvania

    Philadelphia, PA

    Key Differentiators

    • Hematology

  • #4

    Massachusetts General Hospital Cancer Center
    Massachusetts General Hospital Cancer Center

    Boston, MA

    Key Differentiators

    • Hematology

  • #5

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Hematology

Original Source(s)

The regulatory role of IL-37 and IL-38 in CAR-T associated cytokine release syndrome in multiple myeloma

  • by Xiujuan Huang, Hailong Yan, Jiaojiao Bai, Shisan Bao, Yi Wang, Qiuying Gao

  • July 14, 2026

Related Content

Postoperative radiotherapy for resected esophageal squamous cell carcinoma: a systematic review and meta-analysis

Metabolism of myeloid cells in brain tumors

Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report